These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 38275158)
1. The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury. Kobeissy F; Arja RD; Munoz JC; Shear DA; Gilsdorf J; Zhu J; Yadikar H; Haskins W; Tyndall JA; Wang KK Expert Rev Mol Diagn; 2024; 24(1-2):67-77. PubMed ID: 38275158 [TBL] [Abstract][Full Text] [Related]
2. Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients. Chen H; Ding VY; Zhu G; Jiang B; Li Y; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M J Neurotrauma; 2022 Oct; 39(19-20):1329-1338. PubMed ID: 35546284 [TBL] [Abstract][Full Text] [Related]
3. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings. Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Using a Rapid Point of Care Test for Predicting Head Computed Tomography Lesions After Mild Traumatic Brain Injury in a Dutch Multi-Center Cohort. Chayoua W; Visser K; de Koning ME; Beishuizen A; IJmker R; van der Naalt J; Krabbe JG; van der Horn HJ J Neurotrauma; 2024 Jul; 41(13-14):e1630-e1640. PubMed ID: 38326742 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study. Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT; Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263 [TBL] [Abstract][Full Text] [Related]
6. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury. Papa L; Brophy GM; Welch RD; Lewis LM; Braga CF; Tan CN; Ameli NJ; Lopez MA; Haeussler CA; Mendez Giordano DI; Silvestri S; Giordano P; Weber KD; Hill-Pryor C; Hack DC JAMA Neurol; 2016 May; 73(5):551-60. PubMed ID: 27018834 [TBL] [Abstract][Full Text] [Related]
7. Performance of glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) biomarkers in predicting CT scan results and neurological outcomes in children with traumatic brain injury (BRAINI-2 paediatric study): protocol of a European prospective multicentre study. Lorton F; Lagares A; de la Cruz J; Méjan O; Pavlov V; Sapin V; Poca MA; Lehner M; Biberthaler P; Chauviré-Drouard A; Gras-Le-Guen C; Scherdel P; ; BMJ Open; 2024 May; 14(5):e083531. PubMed ID: 38754888 [TBL] [Abstract][Full Text] [Related]
8. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT; J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516 [TBL] [Abstract][Full Text] [Related]
9. Integrated Assessment of GFAP and UCH-L1 for their utility in severity assessment and outcome prediction in Traumatic Brain Injury. Mathew D; Purohit P; Gadwal A; Anil A; Sharma RK; Meshram VP; Setia P Int J Legal Med; 2024 Nov; 138(6):2559-2568. PubMed ID: 38977505 [TBL] [Abstract][Full Text] [Related]
10. Screening Performance of S100 Calcium-Binding Protein B, Glial Fibrillary Acidic Protein, and Ubiquitin C-Terminal Hydrolase L1 for Intracranial Injury Within Six Hours of Injury and Beyond. Trivedi D; Forssten MP; Cao Y; Ismail AM; Czeiter E; Amrein K; Kobeissy F; Wang KKW; DeSoucy E; Buki A; Mohseni S J Neurotrauma; 2024 Feb; 41(3-4):349-358. PubMed ID: 38115670 [TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Blood-Based Brain Biomarkers for Screening Adults with Mild Traumatic Brain Injury in the French Health Care Setting. Zimmer L; McDade C; Beyhaghi H; Purser M; Textoris J; Krause A; Blanc E; Pavlov V; Earnshaw S J Neurotrauma; 2023 Apr; 40(7-8):706-719. PubMed ID: 36267001 [TBL] [Abstract][Full Text] [Related]
12. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury. Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic Performance of GFAP, UCH-L1, and MAP-2 Within 30 and 60 Minutes of Traumatic Brain Injury. Papa L; McKinley WI; Valadka AB; Newman ZC; Nordgren RK; Pramuka PE; Barbosa CE; Brito AMP; Loss LJ; Tinoco-Garcia L; Hinson HE; Schreiber MA; Rowell SE JAMA Netw Open; 2024 Sep; 7(9):e2431115. PubMed ID: 39230905 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Acute Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Plasma Levels in Traumatic Brain Injury Patients with and without Intracranial Lesions. Biberthaler P; Musaelyan K; Krieg S; Meyer B; Stimmer H; Zapf J; von Matthey F; Chandran R; Marino JA; Beligere G; Hoffmann M; Zhang H; Datwyler SA; McQuiston B Neurotrauma Rep; 2021; 2(1):617-625. PubMed ID: 35018363 [TBL] [Abstract][Full Text] [Related]
15. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects. Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301 [TBL] [Abstract][Full Text] [Related]
16. Study protocol for investigating the clinical performance of an automated blood test for glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase L1 blood concentrations in elderly patients with mild traumatic BRAIN Injury and reference values (BRAINI-2 Elderly European study): a prospective multicentre observational study. Lagares A; Payen JF; Biberthaler P; Poca MA; Méjan O; Pavlov V; Viglino D; Sapin V; Lassaletta A; de la Cruz J; BMJ Open; 2023 Jul; 13(7):e071467. PubMed ID: 37460257 [TBL] [Abstract][Full Text] [Related]
17. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats. Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798 [TBL] [Abstract][Full Text] [Related]
18. Accuracy of a rapid glial fibrillary acidic protein/ubiquitin carboxyl-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury. Bazarian JJ; Welch RD; Caudle K; Jeffrey CA; Chen JY; Chandran R; McCaw T; Datwyler SA; Zhang H; McQuiston B Acad Emerg Med; 2021 Nov; 28(11):1308-1317. PubMed ID: 34358399 [TBL] [Abstract][Full Text] [Related]
19. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children. Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142 [TBL] [Abstract][Full Text] [Related]
20. Study protocol for investigating the performance of an automated blood test measuring GFAP and UCH-L1 in a prospective observational cohort of patients with mild traumatic brain injury: European BRAINI study. Richard M; Lagares A; Bondanese V; de la Cruz J; Mejan O; Pavlov V; Payen JF; BMJ Open; 2021 Feb; 11(2):e043635. PubMed ID: 33632753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]